GlassScriptPhysician profile
Hyo Joo Lim
NPI 1023572039
$3,884.05
in general payments reported to CMS, 2019-2025
20 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $692 · 2022: $491 · 2023: $726 · 2024: $713 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,525 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,525.12 |
| Education | $175.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $770.04 | 2021-2025 | |
| Astellas Pharma US INC | $742.28 | 2021-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $466.62 | 2023-2025 | Gemtesa |
| Teleflex LLC | $423.43 | 2021-2025 | Urolift, Barrigel, Twin-Pass |
| Abbvie INC. | $276.13 | 2021-2025 | |
| Boston Scientific Corporation | $244.95 | 2022-2025 | General - Therapies, Watchman Flx, Resonate El Icd Vr |
| Bayer Healthcare Pharmaceuticals INC. | $166.50 | 2025 | |
| Cardiva Medical, INC. | $142.11 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Urovant Sciences INC | $134.53 | 2022 | |
| Amgen INC. | $125.00 | 2021 | |
| Tolmar, INC. | $77.55 | 2023 | |
| Biosense Webster, INC. | $76.76 | 2024 | Carto 3 |
| Abiomed | $63.95 | 2023 | Impella |
| Alnylam Pharmaceuticals INC. | $35.12 | 2025 | Givlaari |
| Urogen Pharma, INC. | $32.76 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $25.22 | 2022 | |
| Janssen Biotech, INC. | $24.99 | 2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $22.70 | 2025 | |
| Philips North America LLC | $19.35 | 2024 | (5154) Azurion 7 M20 Gc |
| B. Braun Interventional Systems INC. | $14.06 | 2025 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyo Joo Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.